Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SwissAnalytic Group is a Swiss-based contract research organization (CRO) specializing in high-end analytical services for the pharmaceutical, chemical, and biotech industries. The company provides a comprehensive suite of services including method development, validation, stability studies, and quality control using advanced techniques such as HPLC, GC, and mass spectrometry. Operating under GMP and ISO standards, SwissAnalytic Group supports clients through the drug development lifecycle, from early-stage R&D to commercial release testing. Their expertise focuses on ensuring the safety, purity, and compliance of complex chemical and biological products. In 2021, the company was acquired by the Tentamus Group, a global network of laboratories, which has expanded its service reach and resources. The firm is recognized for its high-quality Swiss standards and its ability to handle challenging analytical problems for global life science companies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SwissAnalytic Group.